Evidence map›Paper›PMID 38236443›Full record

ReviewMolecular diversity2024

Review on advancements of pyranopyrazole: synthetic routes and their medicinal applications.

Ashok R Yadav, Ashishkumar P Katariya, Anant B Kanagare, Pramod D Jawale Patil, Chandrakant K Tagad, Satish A Dake, Pratik A Nagwade, Satish U Deshmukh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular diversity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ashok R YadavDepartment of Chemistry, Deogiri College, Aurangabad, Maharashtra, 431005, India.
Ashishkumar P KatariyaDepartment of Chemistry, SAJVPM'S Smt. S. K. Gandhi Arts, Amolak Science & P. H. Gandhi, Commerce College, Kada, Beed, Maharashtra, 414202, India.
Anant B KanagareDepartment of Chemistry, Deogiri College, Aurangabad, Maharashtra, 431005, India. anantinostar@gmail.com.
Pramod D Jawale PatilDepartment of Chemistry, Balbhim Arts, Science and Commerce College, Beed, Maharashtra, 431122, India.
Chandrakant K TagadDepartment of Biochemistry, S.B.E.S. College of Science, Aurangabad, Maharashtra, 431001, India.
Satish A DakeDepartment of Chemistry, Sunderrao Solanke Mahavidyalaya, Majalgaon, Maharashtra, 431131, India.
Pratik A NagwadeDepartment of Chemistry, Shri Anand College, Pathardi, Ahmednagar, Maharashtra, 414102, India.
Satish U DeshmukhDepartment of Chemistry, Deogiri College, Aurangabad, Maharashtra, 431005, India. anantinostar@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyranopyrazoles are among the most distinguished, biologically potent, and exciting scaffolds in medicinal chemistry and drug discovery. Synthesis and design of pyranopyrazoles using functional modifications via multicomponent reactions (MCRs) are thoroughly found in synthetic protocols by forming new C-C, C-N, and C-O bonds. This review aims to focus on the biological importance of pyranopyrazoles as well as on a diverse synthetic approach for their synthesis using various catalytic systems such as acid-catalyzed, base-catalyzed, ionic liquids and green media-catalyzed, nano-particle-catalyzed, metal oxide-supported catalysts, and silica-supported catalysts. In this review, we have summarized data on the advancements in synthesizing pyranopyrazole from the last two decades to the mid-2023 and research papers describing the importance of these scaffolds. This review will be significant for synthetic organic chemists and researchers working in organic chemistry.

Indexed as

PyrazolesCatalysisChemistry, PharmaceuticalChemistry Techniques, SyntheticPyransPyransPyrazolesIonic liquids catalyzedMulticomponent reactions (MCRs)Nano-particles catalyzedPyranopyrazolesSilica-supported catalyst

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.